Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Major Histocompatibility Complex (MHC) class I proteins present peptides to CD8+ T cells, crucial for adaptive immunity.
• T cell receptor (TCR) interactions with peptide-MHC (pMHC) influence T cell activation or anergy.
• Understanding these interactions is key for developing immunotherapies and vaccines.

Purpose of the Study:

• To introduce VLP-Open HLA, a novel multivalent platform for displaying peptide-MHC molecules.
• To establish VLP-Open HLA as a tool for screening antigen-specific CD8+ T cells and orphan TCRs.
• To demonstrate VLP-Open HLA's utility as an artificial antigen-presenting system for T cell activation and expansion.

Main Methods:

• Development of a virus-like particle (VLP) platform capable of displaying up to 60 peptide/HLA molecules.
• Utilizing VLP-Open HLA for staining antigen-specific CD8+ T cells.
• Employing VLP-Open HLA with costimulation as an artificial antigen-presenting platform.

Main Results:

• VLP-Open HLA successfully displays a high density of peptide-MHC molecules.
• The platform enables efficient screening of antigen-specific CD8+ T cells and identification of orphan TCRs.
• VLP-Open HLA combined with costimulation effectively induces antigen-specific T cell activation and expansion.

Conclusions:

• VLP-Open HLA offers a versatile and efficient platform for immunological research.
• It serves as a valuable tool for TCR screening and artificial antigen presentation.
• The platform's adaptability to various HLA allotypes and costimulatory molecules expands its potential applications in experimental immunology.